BKV Corporation (NYSE:BKV) Short Interest Update

BKV Corporation (NYSE:BKV) saw a significant growth in short interest in September. As of September 15th, there was short interest totaling 10,035,138 shares, a growth of 64.4% from the August 31st total of 6,102,985 shares. Approximately 9.4% of the company’s stock are short sold. Based on an average trading volume of 3,476,246 shares, the short-interest ratio is currently 2.9 days.

BKV Stock Up 0.9%

NYSE:BKV traded up $0.19 during mid-day trading on Thursday, reaching $21.53. The stock had a trading volume of 1,066,059 shares, compared to its average volume of 1,080,761. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.15 and a quick ratio of 1.10. The company has a market capitalization of $2.36 billion, a price-to-earnings ratio of 7.86 and a beta of 1.06. BKV has a 1-year low of $20.08 and a 1-year high of $32.81. The stock’s 50 day simple moving average is $24.41 and its two-hundred day simple moving average is $26.37.

BKV (NYSE:BKV) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.21. BKV had a return on equity of 6.67% and a net margin of 17.73%.The firm had revenue of $465.54 million for the quarter, compared to analysts’ expectations of $355.25 million. Equities analysts anticipate that BKV will post 1.62 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on BKV shares. Susquehanna cut their target price on BKV from $37.00 to $35.00 and set a “positive” rating on the stock in a research report on Tuesday, July 21st. Jefferies Financial Group reissued a “buy” rating and set a $34.00 price target on shares of BKV in a research report on Friday, July 10th. Zacks Research upgraded shares of BKV from a “strong sell” rating to a “hold” rating in a research note on Monday, June 15th. Weiss Ratings lowered shares of BKV from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, September 14th. Finally, Raymond James Financial set a $29.00 price target on shares of BKV in a report on Tuesday, September 15th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, BKV currently has a consensus rating of “Moderate Buy” and a consensus price target of $33.56.

Insider Activity

In other news, insider Lindsay Larrick sold 10,000 shares of BKV stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $26.16, for a total transaction of $261,600.00. Following the sale, the insider directly owned 83,925 shares of the company’s stock, valued at approximately $2,195,478. The trade was a 10.65% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO David Tameron sold 1,500 shares of the business’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $25.63, for a total value of $38,445.00. Following the completion of the transaction, the chief financial officer owned 57,024 shares in the company, valued at approximately $1,461,525.12. This trade represents a 2.56% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 35,626 shares of company stock worth $901,589 over the last ninety days. Corporate insiders own 2.51% of the company’s stock.

Institutional Investors Weigh In On BKV

Institutional investors and hedge funds have recently made changes to their positions in the company. Bank of New York Mellon Corp acquired a new position in BKV in the second quarter worth $15,261,000. Value Aligned Research Advisors LLC increased its stake in BKV by 110.5% during the second quarter. Value Aligned Research Advisors LLC now owns 679,899 shares of the company’s stock valued at $18,602,000 after purchasing an additional 356,848 shares during the last quarter. William Blair Investment Management LLC acquired a new stake in shares of BKV during the second quarter worth $32,689,000. Moore Capital Management LP acquired a new stake in shares of BKV during the second quarter worth $2,001,000. Finally, SIR Capital Management L.P. bought a new position in shares of BKV in the 2nd quarter worth about $1,135,000.

About BKV

BKV Corporation is an energy company focused on natural gas production and related energy-transition solutions. The company explores for, develops and produces natural gas and natural gas liquids, with operations primarily centered in major U.S. shale basins.

BKV’s activities include upstream oil and gas development, natural gas marketing and midstream services. The company also develops carbon capture, utilization and storage projects intended to reduce emissions associated with natural gas production and use, as well as renewable natural gas initiatives.

Based in Denver, Colorado, BKV serves U.S.